510(k) Report

De Novo · Granted

Granted

X-Ray Attenuating Cream

DEN120022De NovoGranted May 9, 2013183-day reviewClass II21 CFR 892.6510

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Bloxr Corporation · PDK Cream For X-Ray Attenuation

Granted on May 9, 2013 as a new device type through De Novo after a 183-day review. 1 later device descends from it.

Decided
May 9, 2013
Review
183 days
Class
Class II
Product code
PDK
Recalls
None

1 later device descends from it, 1 citing it directly.

Descendants, by year cleared 2014: 1 descendant cleared2010201520202025
  1. This deviceDEN120022 X-Ray Attenuating CreamBloxr Corporation · 2013
  2. Descendant · cites it directly · 0 of its ownK133684 UltrabloxBloxr Corporation · 2014

Most influential descendants

Showing 1 of 1 · See all
  • K133684UltrabloxBloxr Corporation · 2014 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)DEN120022X-Ray Attenuating CreamBloxr Corporation2013—
+1K133684UltrabloxBloxr Corporation2014—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201410
FIG. 1 — Lineage of DEN120022, 2013–2014Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA De Novo database (decision fields), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in PDK? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

Does it have a predicate?

De Novo decisions do not claim a predicate device.

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K133684UltrabloxBloxr Corporation20140

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K133684 (Bloxr Corporation, 2014) has gone furthest, with 0 descendants of its own.

How does its category compare?

All PDK devices

PDK Cream For X-Ray Attenuation: FDA decisions, review times, recalls and adverse event reports over 20 years. 2013, this device’s year, is highlighted.

FDA decisions per year · PDK

1in 2014

2013: 12014: 1
2007high 1 (2013) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · PDK

Too few PDK 510(k)s in any year since 2007 to give a median.

Recalls per year · PDK

No recall names PDK since 2007.

Adverse event reports per year · PDK

No MAUDE report names PDK since 2007.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20131—00
20141—00
20150—00
20160—00
20170—00
20180—00
20190—00
20200—00
20210—00
20220—00
20230—00
20240—00
20250—00
20260—0—
Cite this page

510(k) Report. “DEN120022: X-Ray Attenuating Cream.” Lineage record from FDA De Novo data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/DEN120022

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026